Perigon Wealth Management LLC Lowers Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Perigon Wealth Management LLC reduced its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 17.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 38,036 shares of the company’s stock after selling 8,305 shares during the period. Perigon Wealth Management LLC owned approximately 0.07% of ARK Genomic Revolution ETF worth $922,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ARKG. Union Bancaire Privee UBP SA bought a new stake in ARK Genomic Revolution ETF during the fourth quarter worth about $45,000. National Bank of Canada FI raised its holdings in shares of ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after buying an additional 920 shares in the last quarter. IHT Wealth Management LLC bought a new stake in ARK Genomic Revolution ETF in the 3rd quarter worth approximately $203,000. Sanctuary Advisors LLC purchased a new stake in ARK Genomic Revolution ETF in the second quarter worth approximately $222,000. Finally, Hilltop Holdings Inc. bought a new position in ARK Genomic Revolution ETF during the third quarter valued at approximately $237,000.

ARK Genomic Revolution ETF Trading Up 15.4 %

ARKG stock opened at $27.25 on Friday. The business’s 50 day simple moving average is $25.17 and its 200 day simple moving average is $25.20.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.